A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Post-menopausal osteoporosis is considered to be an inflammatory process, in which numerous pro-inflammatory and T-cell-derived cytokines play a bone-destructive role. IL-17A is the signature cytokine of the pro-inflammatory Th17 population and plays dichotomous roles in diseases that affect bone turnover. Although IL-17A promotes bone loss in rheumatoid arthritis, it is protective against pathogen-induced bone destruction in a periodontal disease model. We used a model of ovariectomy-induced osteoporosis (OVX) in IL-17 receptor (IL-17RA)(-/-) mice to evaluate the role of the IL-17A in bone loss caused by estrogen deficiency. Unexpectedly, IL-17RA(-/-) mice were consistently and markedly more susceptible to OVX-induced bone loss than controls. There were no changes in prototypical Th1, Th2 or Th17 cytokines in serum that could account for increased bone loss. However, IL-17RA(-/-) mice exhibited constitutively elevated leptin, which further increased following OVX. Consistently, IL-17A and IL-17F treatment of 3T3-L1 pre-adipocytes inhibited adipogenesis, leading to reduced production of leptin. In addition to its role in regulating metabolism and satiety, leptin can regulate bone turnover. Accordingly, these data show that IL-17A negatively regulates adipogenesis and subsequent leptin expression, which correlates with increased bone destruction during OVX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice deficient in IL-17 and fed regular chow gain increased fat mass with age, corresponding to a role for IL-17 in regulating glucose homeostasis and inhibiting adipogenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Goswami et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“IL-17A and the related cytokine IL-17F are produced by a newly-discovered subset of T helper lymphocytes, termed Th17 cells [2].”
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 2×
“TGFβ controls Th17 differentiation, together with IL-6 and IL-1 (reviewed in [3]).”
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554 · cited 1×
“In addition, Th17 cells express high levels of RANKL, providing a direct mechanism by which they may drive mediate bone destruction [5].”
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 1×
“IL-17A induces production of TNF-α and IL-1β in macrophages [6], and synergizes with IL-1β and TNF-α in many cell backgrounds to increase the synthesis of pro-inflammatory effectors such as IL-6, IL-8 and matrix mellaproteinases [7,8].”
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · cited 1×
“RANKL is inhibited by a soluble decoy receptor OPG (osteoprotegerin), which binds to RANK and prevents osteoclastogenesis [31,32].”
BackgroundIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.2.115 · Cited by 1,318
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance
Ducy, P., Schinke, T., & Karsenty, G. (2000) · Science · doi:10.1126/science.289.5484.1501 · Cited by 1,120 · cited 1×
“Leptin has been shown to cause bone loss through a central pathway in the hypothalamus [27].”
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Mice deficient in IL-17 and fed regular chow gain increased fat mass with age, corresponding to a role for IL-17 in regulating glucose homeostasis and inhibiting adipogenesis (Ahmed and Gaffen, 2013; Goswami et al., 2009; Zuniga et al., 2010).”
BackgroundSelf-citationOsteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
“However, inconsistent results have been reported on the role of IL-17 receptor IL-17RA in the pathogenesis of estrogen deficiency-induced osteoporosis; IL-17RA-deficient mice reportedly have a lower bone mineral density than wildtype mice after Ovx (141).”
ResultIL-17 regulates adipogenesis, glucose homeostasis, and obesity
Zúñiga, L. A., Shen, W.-J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M., Cua, D. J., Kraemer, F. B., & Butcher, E. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001269 · Cited by 394
Vitamin D and Bone Health; Potential Mechanisms
Laird, E., Ward, M., McSorley, E., Strain, J. J., & Wallace, J. (2010) · Nutrients · doi:10.3390/nu2070693 · Cited by 358
Tyagi, A. M., Srivastava, K., Mansoori, M. N., Trivedi, R., Chattopadhyay, N., & Singh, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044552 · Cited by 326
“While the studies by Goswami et al, 2009 [26] have shown that Ovx IL-17 receptor knockout mice were more susceptible to bone loss than controls thus suggesting a bone protective role for IL-17 receptor signalling, contrasting observations by our group [27] and DeSelm et al [28] suggested that IL-17…”
ResultIL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
“Although no changes in Th1, Th2, orTh17 cytokines were detected in serum, constitutively elevated leptin, a factor that regulates metabolism and satiety, but also bone metabolism, was further increased following ovariectomy and suggested as a putative mechanism to account for exaggerated bone loss [282].”
BackgroundPhysiological and pathophysiological bone turnover — role of the immune system
Weitzmann, M. N., & Ofotokun, I. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.91 · Cited by 240
Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
Gravallese, E. M., & Schett, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0091-8 · Cited by 223
IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
Adamopoulos, I. E., Tessmer, M., Chao, C.-C., Adda, S., Gorman, D., Petro, M., Chou, C.-C., Pierce, R. H., Yao, W., Lane, N. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003986 · Cited by 200
Proinflammatory T cells and IL-17 stimulate osteoblast differentiation
Croes, M., Öner, F. C., van Neerven, D., Sabir, E., Kruyt, M. C., Blokhuis, T. J., Dhert, W. J. A., & Alblas, J. (2016) · Bone · doi:10.1016/j.bone.2016.01.010 · Cited by 196
“[62].”
IL-17 in obesity and adipogenesis
Ahmed, M., & Gaffen, S. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.005 · Cited by 185
“Goswami et al, 2009 Human bone marrowderived mesenchymal stem cells - IL-17A inhibited adipocyte differentiation of hBM-MSCs via COX-2 induction.”
InfluentialRole of T cells in ovariectomy induced bone loss—revisited
Pacifici, R. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1500 · Cited by 142
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
DeSelm, C. J., Takahata, Y., Warren, J., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24165 · Cited by 125
“…bone mass. DEXA measurements of bone density are influenced by fat distribution [Hangartner and Johnston, 1990; Formica et al., 1995; Tothill et al., 1997, 1999; Wren et al., 2007], which is potentially affected by IL-17 [Goswami et al., 2009; Shin et al., 2009; Sumarac-Dumanovic et al., 2009].”
BackgroundThe Pathogenesis of Ankylosing Spondylitis: an Update
Pedersen, S. J., & Maksymowych, W. P. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0856-3 · Cited by 115
Cline-Smith, A., Axelbaum, A., Shashkova, E., Chakraborty, M., Sanford, J., Panesar, P., Peterson, M., Cox, L., Baldan, A., Veis, D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3966 · Cited by 108
IL-17RC: a partner in IL-17 signaling and beyond
Ho, A. W., & Gaffen, S. L. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0185-0 · Cited by 104
“Recently, using a murine model of ovariectomyinduced osteoporosis, IL-17RA signaling was shown to protect from systemic bone loss due to estrogen deficiency [100].”
Self-citationThe metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Cytokines and inflammation in adipogenesis: an updated review
Jiang, N., Yao, L., Shu, T., & Wang, J. (2019) · Frontiers of Medicine · doi:10.1007/s11684-018-0625-0 · Cited by 114
Batool, H., Nadeem, A., Kashif, M., Shahzad, F., Tahir, R., & Afzal, N. (2018) · BioMed Research International · doi:10.1155/2018/8531961 · Cited by 101
“gingivalis) induces IL-17, the protective role of IL-17 against bone destruction has also been suggested [12, 16].”
BackgroundIL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors
Ahmed, M., & Gaffen, S. L. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.007 · Cited by 86
“Consistently, IL-17A / and IL-17R / mice are overweight, show defects in glucose metabolism, and experience enhanced bone loss during osteoporosis [14,15].”
BackgroundIL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis
Shaw, A. T., Maeda, Y., & Gravallese, E. M. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0998-x · Cited by 82
“IL-17 signaling suppresses adipogenesis and promotes osteoblast differentiation from MSCs, suggesting that IL-17 is bone protective [15].”
BackgroundInterleukin-17A Interweaves the Skeletal and Immune Systems
Tang, M., Lu, L., & Yu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625034 · Cited by 86
Estrogen increases, whereas IL‐27 and IFN‐γ decrease, splenocyte IL‐17 production in WT mice
Khan, D., Dai, R., Karpuzoglu, E., & Ahmed, S. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040303 · Cited by 70
“Additionally, IL-17A has been shown to promote osteoblastogenesis by suppressing leptin in estrogen-deficiency induced bone loss [5].”
BackgroundThe role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases
Chen, Y., Yu, C., & Deng, W. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1645138 · Cited by 72
Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells
Noh, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.010 · Cited by 72
“IL-17A not only promotes osteogenesis in hBM-MSCs, but also it regulates bone metabolism [11,12].”
BackgroundKe, D., Fu, X., Xue, Y., Wu, H., Zhang, Y., Chen, X., & Hou, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.164 · Cited by 75
Immune regulation of bone loss by T h17 cells in oestrogen‐deficient osteoporosis
Zhao, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12158 · Cited by 66
Feng, Y., Chen, Z., Tu, S.-Q., Wei, J.-M., Hou, Y., Kuang, Z., Kang, X.-N., & Ai, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862415 · Cited by 70
To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis
Perrotta, F. M., Lories, R. J. U., & Lubrano, E. (2021) · RMD Open · doi:10.1136/rmdopen-2020-001480 · Cited by 56
“29 The direct role of IL-17 in the pathogenesis of new bone formation is still a matter of debate: while some studies demonstrated that bone loss induced by ovariectomy was increased in mice deficient for IL-17 receptor A (IL-17RA), and thus suggesting a protective and anabolic role of IL-17, 30 other evidence showed…”
InfluentialThe outliers become a stampede as immunometabolism reaches a tipping point
Nikolajczyk, B. S., Jagannathan‐Bogdan, M., & Denis, G. V. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01142.x · Cited by 58
Interleukin-17 as a key player in neuroimmunometabolism
Douglas, A., Stevens, B., & Lynch, L. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00846-3 · Cited by 49
Osteoimmunology and Its Implications for Transplantation
Pacifici, R. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12380 · Cited by 40
Xue, Y., Liang, Z., Fu, X., Wang, T., Xie, Q., & Ke, D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.029 · Cited by 38
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent
Sabbieti, M. G., Agas, D., Capitani, M., Marchetti, L., Concetti, A., Vullo, C., Catone, G., Gabai, V. L., Shifrin, V. I., Sherman, M. Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2884 · Cited by 33
“The inhibitory effect of p62 DNA extended to an array of cytokines such as TNFα, IL6, IL1b IL17, all known to be essential inducers of inflammatory diseases and bone loss [21].”
BackgroundThe dual role of IL-17 in periodontitis regulating immunity and bone homeostasis
Tang, Z., Jin, L., & Yang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1578635 · Cited by 45
Regulation of systemic metabolism by tissue-resident immune cell circuits
Li, J. H., Hepworth, M. R., & O’Sullivan, T. E. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.001 · Cited by 39
Exercise and osteoimmunology in bone remodeling
Zhao, Z., Du, Y., Yan, K., Zhang, L., & Guo, Q. (2024) · The FASEB Journal · doi:10.1096/fj.202301508rrr · Cited by 40
“143 Scheffler J M et al. 144 also found that the bone marrow adipose tissue of ovariectomized mice with IL-17A KO was enlarged and the bone turnover was reduced.”
BackgroundCell biology of osteoimmunology
Gruber, R. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0809-y · Cited by 31
“bone loss than controls, indicating that IL-17 may have some bone protective functions [ 36 ].”
BackgroundFanganiello, R. D., Ishiy, F. A. A., Kobayashi, G. S., Alvizi, L., Sunaga, D. Y., & Passos‐Bueno, M. R. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9592-x · Cited by 30
Cells of the Immune System Orchestrate Changes in Bone Cell Function
Wythe, S. E., Nicolaidou, V., & Horwood, N. J. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9764-0 · Cited by 38
“They concluded that IL17A negatively regulates adipogenesis and subsequent leptin expression, which correlates with increased bone destruction following OVX [61].”
BackgroundBalani, D., Aeberli, D., Hofstetter, W., & Seitz, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37762 · Cited by 37
Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss
Khosla, S., & Pacifici, R. (2013) · Osteoporosis · doi:10.1016/b978-0-12-415853-5.00046-7 · Cited by 31
Elevated levels of Th17 cells in children with central obesity
Łuczyński, W., Grubczak, K., Moniuszko, M., Głowińska‐Olszewska, B., & Bossowski, A. T. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1066845 · Cited by 33
Pedersen, S. J., & Maksymowych, W. P. (2018) · Drugs · doi:10.1007/s40265-018-0971-x · Cited by 31
Sritharan, S., Kannan, T. P., Norazmi, M. N., & Nurul, A. A. (2018) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2018.05.002 · Cited by 23
Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo
Zhong, J., Wang, Z., Yuan, W., Shen, Y., & Chen, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108631 · Cited by 26
Interleukin 17A: a Janus-faced regulator of osteoporosis
Scheffler, J. M., Grahnemo, L., Engdahl, C., Drevinge, C., Gustafsson, K. L., Corciulo, C., Lawenius, L., Iwakura, Y., Sjögren, K., Lagerquist, M. K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62562-2 · Cited by 25
14-3-3ζ: A suppressor of inflammatory arthritis
Kim, J. P., Chun, K. M., McGowan, J., Zhang, Y., Czernik, P. J., Mell, B., Joe, B., Chattopadhyay, S., Holoshitz, J., & Chakravarti, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025257118 · Cited by 23
Association between leptin and systemic lupus erythematosus
Xu, W., Zhang, M., Zhang, Y., Liu, S., Pan, H., & Ye, D. (2013) · Rheumatology International · doi:10.1007/s00296-013-2774-4 · Cited by 21
“deficiency [17], where the mice exhibited constitutively elevated leptin, which further increased following OVX.”
BackgroundRoberts, J. L., Mella-Velazquez, G., Dar, H. Y., Liu, G., & Drissi, H. (2021) · Bone · doi:10.1016/j.bone.2021.116310 · Cited by 19
Physiological roles of human interleukin‐17 family
Liu, Y., Ouyang, Y., You, W., Liu, W., Cheng, Y., Mai, X., & Shen, Z. (2023) · Experimental Dermatology · doi:10.1111/exd.14964 · Cited by 25
“146 On the other side, clinical human studies show Th17 All these studies indicate that IL-17 is involved in human bone metabolism.”
BackgroundHalofuginone prevents estrogen‐deficient osteoporosis in mice
DeSelm, C. J., Zou, W., & Teitelbaum, S. L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24185 · Cited by 18
“IL17 receptor-deficient mice are heavier and have higher leptin levels, a marker of adopocyte mass [Goswami et al., 2009; Galic et al., 2010].”
BackgroundHemdan, N. Y. A., El-Saad, A. M. A., & Sack, U. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/374769 · Cited by 21
“…micromolar concentrations of Cd2+ andHg2+ induces a robust TH17 response, that was also inferred bymild but significant increase of IL-17 profile in serum of individuals occupationally exposed to the same metals, as well as a robust ex vivo TH17 response (N. Y. A. Hemdan et al., unpublished data).”
BackgroundWu, T., Chen, L., Ye, N., Fu, R., Liu, L., Yu, F., Wang, X., Chang, J., Fang, B., Wu, C., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202302054 · Cited by 21
Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis
Klavdianou, K., Kanellou, A., & Daoussis, D. (2022) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.33.1.115 · Cited by 21
Jung, C., Lichtenauer, M., Strodthoff, D., Winkels, H., Wernly, B., Bürger, C., Kamchybekov, U., Lutgens, E., Figulla, H., & Gerdes, N. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12435 · Cited by 14
Jamali, Z., Arababadi, M. K., & Asadikaram, G. (2012) · Inflammation · doi:10.1007/s10753-012-9531-9 · Cited by 17
Mukherjee, S., Agarwal, M. G., Bakshi, A. V., Sawant, S., Thomas, L. V., Fujii, N., Nair, P. D., & Kode, J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01134 · Cited by 13
Melhus, G., Brorson, S. H., Bækkevold, E. S., Andersson, G., Jemtland, R., Olstad, O. K., & Reinholt, F. P. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9371-2 · Cited by 11
“However, IL17RA null mice exhibit more pronounced bone loss compared to wildtype mice following OVX [38]; and thus, the role of this interleukin and its receptor seems diverse.”
BackgroundInhibition of IL‐17 prevents the progression of traumatic heterotopic ossification
Tu, B., Yu, B., Wang, W., Li, J., Yuan, F., Zhu, J., & Fan, C. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16617 · Cited by 12
Animal Models in Bone Research
Kimmel, D. B. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_4 · Cited by 10
Kuang, S., Ma, X., Sun, L., Wang, C., Yang, L., Wang, G., Sun, J., Zhou, F., & Zhang, C. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s510102 · Cited by 8
Interleukin‐17 regulates visceral obesity in HIV‐1‐infected patients
Zizza, A., Guido, M., & Grima, P. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2012.01014.x · Cited by 7
Immune-related gene IL17RA as a diagnostic marker in osteoporosis
Deng, Y.-J., Li, Z., Wang, B., Li, J., Ma, J., Xue, X., Tian, X., Liu, Q.-C., Zhang, Y., & Yuan, B. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1219894 · Cited by 6
Sritharan, S., Kannan, T. P., Norazmi, M. N., & Nurul, A. A. (2016) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-016-9529-5 · Cited by 6
“Several clinical studies have indicated a pivotal role for IL-17 involvement in bone remodeling, either in enhancing or aggravating osteogenesis, depending on the microenvironment involved (Goswami et al. 2009; Huang et al. 2009; Kwan Tat et al. 2008; Moon et al. 2012).”
InfluentialInterleukin-21 knockout reduces bone loss in ovariectomized mice by inhibiting osteoclastogenesis
Hou, J., Xu, P., Zhong, Y., Zhou, Z., & Zhang, W. C. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad103 · Cited by 7
Lokale und systemische Knocheneffekte bei rheumatoider Arthritis
Rauner, M., Hofbauer, L. C., & Aringer, M. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0927-y · Cited by 7
Sritharan, S., Kannan, T., Mn, N., & Nurul, A. A. (2014) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v13i2.474 · Cited by 4
Reyes-Sánchez, A. A., & Obil-Chavarría, C. A. (2016) · Journal of Spine · doi:10.4172/2165-7939.1000295 · Cited by 2
Zhang, X. Y. (2024) · Journal of International Medical Research · doi:10.1177/03000605241239841 · Cited by 4
“However, other studies have not reached the same conclusions, Goswami et al. 36 conducted animal experiments on excessive weight gain in mice lacking interleukin (IL)-17A receptors; their findings suggested that IL-17 inhibits the growth of adipose tissue.”
ResultNon-neuronal cholinergic stimulation favors bone mass accrual
Tamimi, F., Eimar, H. A., Alebrahim, S., Nada, L. A., Manickam, G., Subaie, A. E. A., Tamimi, I., & Murshed, M. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1684102 · Cited by 2
Advances in the Role of Adipose Tissue in Promoting Injury Repair and Resist Infection
Duan, X., Li, R., Fu, L., Yang, J., & Zhan, Z. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70341 · Cited by 5
“IL‐17A and IL‐17F treatment of 3T3‐L1 pre‐adipocytes inhibited adipogenesis, leading to reduced production of leptin [125]; this may, in turn, affect inflammation within AT (Figure 2).”
Jin, Z., Liu, L., Wang, H., Wei, Y., Zhou, Z., Luo, X., & Liu, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117219 · Cited by 4
Wang, Q., Wang, X., Wu, K., Wu, W., 韦展图, & Feng, W. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303335018241107084224 · Cited by 1
Tsarenok, S. Y., Gorbunov, V. V., & Ta, A. (2014) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2014-3-41-44 · Cited by 2
Osteoclast Signal Transduction Pathways: The RANKL/RANK System
Yao, Z., & Boyce, B. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62203-1 · Cited by 1
Wu, T., Chen, L., Ye, N., Fu, R., Liu, L., Yu, F., Wang, X., Chang, J., Fang, B., Wu, C., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3919725 · Cited by 1
Production and role of IL-17 and related cytokines in response to respiratory pathogens
MacPherson, A. (2012) · Enlighten: Theses (The University of Glasgow)
THE ROLE OF TNF-β AND IL-17A IN POSTMENOPAUSAL OSTEOPOROSIS
Behrouzi, A., Hadi, H. A., Ghandi, A., & Mosayebi, G. (2014)
Treg regulation in periodontal disease during pregnancy.
Hays, A. L. (2017) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2685
Kobayashi, G. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2016.tde-26082016-165134 · Cited by 2
Kırali, B., KUNDAK, K., Doğan, B., & Kuru, L. (2023) · European Journal of Research in Dentistry · doi:10.29228/erd.46
胡守奎, Fang, Y., Ma, H., & Huang, J. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120868
Neutrophil heterogeneity under IL-17A deficiency in experimental periodontitis
Tang, Z., Hu, R., Zhu, L., Hu, J., Xiao, F., Jin, L., Lu, L., & Yang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1963694
The Roles of IL-17A and IL-17F in Infection and Inflammatory Disorders
Ishigame, H., & Nakae, S. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_3
Metadata
- Authors
- Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Stanford University (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2009-10
- Volume
- 39
- Issue
- 10
- Pages
- 2831-2839
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC2811493
- OpenAlex
- W2122724238
- Cited by
- 87
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 9 · 2012: 11
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- State University of New York
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (F31-AI073198-02, F31AI073198)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- National Institute of Dental and Craniofacial Research (DE019424, R01DE019424)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17A, IL-17 receptor, ovariectomy-induced bone loss, postmenopausal osteoporosis, estrogen deficiency, leptin, adipogenesis, 3T3-L1 preadipocytes, Th17 cells, bone turnover, IL-17F
- MeSH terms
- Animals, Estrogens, Female, Mice, Inbred C57BL, Models, Biological, Osteoporosis, Ovariectomy, Spine, Tumor Necrosis Factor-alpha, Signal Transduction, Weight Gain, Bone Density, Down-Regulation, Cytokines, Adipocytes, Mice, Knockout, Interleukin-17, Leptin, 3T3-L1 Cells, Adipogenesis, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.